Mitochondrial dysfunction plays a pivotal role in the cell toxicology and death decision. The aim of the present study was to investigate the effect of three organocompounds (ebselen [Ebs], diphenyl diselenide [(PhSe) 2 ] and diphenyl ditelluride [(PhTe) 2 ]) on mitochondrial complexes (I, II, I-III, II-III and IV) activity from rat liver and kidney to determine their potential role as molecular targets of organochalcogens. All studied organochalcogens caused a statistically significant inhibition of the mitochondrial complex I activity. Ebs and (PhTe) 2 caused a statistically significant inhibition of the mitochondrial complex II activity in both hepatic and renal membranes. Hepatic mitochondrial complex II activity was practically unchanged by (PhSe) 2 , whereas it significantly inhibited renal complex II activity. Mitochondrial complex IV activity was practically unchanged by the organochalcogens. Furthermore, organochalcogens inhibited the mitochondrial respiration supported by complex I or complex II substrates. The inhibitory effect of Ebs, (PhSe) 2 and (PhTe) 2 on mitochondrial complex I was prevented by NADH, but it was not prevented by catalase (CAT) and/or superoxide dismutase (SOD). Additionally, the organochalcogens-induced inhibition of complex I and II was completely reversed by reduced glutathione (GSH). In conclusion, Ebs, (PhSe) 2 and (PhTe) 2 were more effective inhibitors of renal and hepatic mitochondrial complex I than complex II, whereas complexes III and IV were little modified by these compounds. Taking into account the presented results, we suggest that organochalcogen-induced mitochondrial complexes I and II inhibition can be mediated by their thiol oxidation activity, i.e., Ebs, (PhSe) 2 and (PhTe) 2 can oxidize critical thiol groups from mitochondrial complexes I and II. So, mitochondrial dysfunction can be considered an important factor in the toxicity of Ebs, (PhSe) 2 and (PhTe) 2 .
Introduction
Living organisms use a series of integral membrane protein complexes for energy conversion and ATP synthesis (Hatefi, 1985) . In addition to their crucial role in energy production and metabolic pathways, the mitochondrial complexes also play key roles in integrating cell death stimuli and executing the apoptotic program (Navarro and Boveris, 2007) . Accordingly, several human diseases, such as Alzheimer's disease, Friedreich's ataxia, familial amyotrophic lateral sclerosis, and Huntington's disease, are associated with mitochondrial electron transport chain inhibition, energy metabolism impairment and oxidative stress (Beal, 1998; Nicholls and Budd, 2000) . Additionally, biochemical studies indicate a decline of electron transport and in some bioenergetic activities of mitochondria during aging and ischemia-reperfusion (Cadenas and Davies, 2000; Caspersen et al., 2005; Cortopassi and Wong, 1999; Hagen et al., 1998; Hauptmann et al., 2006; Navarro and Boveris, 2007; Nicholls, 2002; Saris and Eriksson, 1995; Sastre et al., 2003) . Thus, mitochondrial dysfunction can be associated with different degenerative cellular processes.
Organoselenium and organotellurium compounds have been extensively studied because of their potential antioxidant capacity (Arteel and Sies, 2001; Barbosa et al., 2006 Barbosa et al., , 2008 de Bem et al., 2009; de Freitas et al., 2009; Hort et al., 2011; Moretto et al., 2007; Nogueira and Rocha, 2011; Parnham and Graf, 1991; Prauchner et al., 2011; Prigol et al., 2008; Puntel et al., 2007) . In line with this, literature data have indicated that these compounds can provide protective effect against lipid peroxidation induced by a variety of pro-oxidants agents (Barbosa et al., 2006 (Barbosa et al., , 2008 Moretto et al., 2007; Rocha, 2010, 2011; Parnham and Graf, 1991; Puntel et al., 2007; Rossato et al., 2002) . The antioxidant activity of these organochalcogens has been ascribed either to their glutathione peroxidase-like activity (Maiorino et al., 1988; Santos et al., 2005; Sies, 1993 Sies, , 1995 or to the fact that they can be substrates 0887-2333 Ó 2012 Elsevier Ltd. http://dx.doi.org/10.1016/j.tiv.2012.10.011 of mammalian thioredoxin reductase (de Freitas and Rocha, 2011; Sausen de Freitas et al., 2010; . Thus, in order to exert antioxidant properties, the selenium containing compounds have to be metabolized to selenol/selenolate intermediates, a reaction which can be accomplished via reduction of the Se moiety by different types of thiols (Nogueira and Rocha, 2011; Wendel et al., 1984 ) (Scheme 1). For organotellurium compounds, it has been postulated that the antioxidant activity is linked to changes in the oxidation state of the Te atom (Te(II) M Te(IV)) (Engman et al., 1995; Leonard et al., 1996; You et al., 2003) .
Thus, the thiol-peroxidase or thioredoxin-thiol-peroxidase-like activity of organochalcogens (Nogueira and Rocha, 2011; Sausen de Freitas et al., 2010; can be of biological and therapeutic significance via artificial modulation of the cellular levels of peroxides. However, the excessive oxidation of thiols, including those in mitochondrial membranes, by organochalcogens without a concomitant reduction of peroxides may be toxic to living cells (thiol-oxidation activity) (Nogueira and Rocha, 2011; Puntel et al., 2010 ) (Scheme 1). In effect, mitochondrial dysfunction caused by thiol oxidation is closely related to the apoptotic cell death (Morin et al., 2003; Zhao et al., 2006) . Accordingly, the organochalcogens should be considered as putative candidates for apoptotic cell death inducer via mitochondrial dysfunction, which may explain, at least in part, their pharmacological/toxicological action (Ardais et al., 2010; Nogueira and Rocha, 2010; Santos et al., 2009a,b) . In line with this, recently our group showed that both Ebselen (Ebs) and diphenyl diselenide [(PhSe) 2 ] induced mitochondrial dysfunction via interaction with critical mitochondria thiols (Puntel et al., 2010) .
Considering that mitochondrial complexes play a central role in cellular metabolism and in the regulation of apoptotic cell death, we sought to determine whether these mitochondrial complexes could be considered molecular targets for the thiol-oxidation activity of Ebs, (PhSe) 2 or diphenyl ditelluride [(PhTe) 2 ]. Specifically, our main objective in this study was to determine whether Ebs, (PhSe) 2 and (PhTe) 2 could cause mitochondrial complex(es) I, II, I-III, II-III and IV inhibition using mitochondrial membranes prepared from rat liver and kidney. We also determined whether organochalcogens could cause mitochondrial respiration inhibition using intact mitochondria in order to better understand their toxicological site of action at the molecular level.
Materials and methods

Chemicals
Chemicals, including NADH, mannitol, rotenone, succinic acid, malonate, potassium cyanide (KCN), sucrose, HEPES and cytochrome c were obtained from Sigma Chemical Company (St Louis, MO, USA). All other reagents were commercial products of the highest purity grade available.
Animals
Adult male Wistar rats (250-350 g) from our own breeding colony were used in this study. The animals were housed in plastic cages with water and food ad libitum, at 22-23°C, 56% humidity, and 12 h light cycle. The diet of the rats containing (in g/100 g): 52 carbohydrate, 20 crude protein, 5 fat, 6 crude fiber, 5 minerals and 11 moisture. Diet contained 0.1 mg/kg of Se and 30 IU/kg of vitamin E (for complete mineral and vitamin contents, see reference (Puntel et al., 2010) ). The protocol was approved by the Institutional Animal Care and Use Committee of Federal University of de Santa Maria (42/2010) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals.
Isolation of rat liver and kidney mitochondria and mitochondrial membranes preparation
Liver and kidney mitochondria were isolated in a solution containing 0.23 M mannitol, 0.07 M sucrose, 15 mM HEPES (pH 7.2) at a ratio of 1 g of tissue/9 mL of homogenization medium in a Potter homogenizer with a Teflon pestle. The homogenate was centrifuged at 700g for 10 min, and the supernatant centrifuged at 8000g for 10 min to yield a mitochondria pellet that was washed once in the same buffer. Mitochondrial protein concentration was adjusted to 20 mg/mL (Peterson, 1977) and the samples were immediately frozen and kept at À80°C. Mitochondria were disrupted and homogenized by twice freezing and thawing and by passage through 15/10 tuberculin needles to produce the mitochondrial membrane preparation according to (Navarro et al., 2002) which were used to the mitochondrial complexes activity assay. In order to study the organochalcogens effect on mitochondrial respiration (oxygen consumption measurements) intact mitochondria were used.
Mitochondrial complexes activities assay
The activities of complexes I, I-III, II, II-III, and IV were determined spectrophotometrically at 30°C with mitochondrial membranes (0.5 mg/mL) suspended in 100 mM phosphate buffer (pH 7.4) as previously described (Navarro et al., 2002 (Navarro et al., , 2004 ) with minor modifications. The mitochondrial membranes were pre-incubated in phosphate buffer in the presence of different organochalcogens concentration (Ebs 0-50 lM; [(PhSe) 2 ] 0-100 lM; [(PhTe) 2 ] 0-100 lM, vehicle (DMSO), or the respective classical inhibitor (positive controls) for 10 min. After pre-incubation, the reaction was started with the addition of the corresponding substrate, except for the experiments using reduced glutathione (GSH), as described Scheme 1. Thiol peroxidation and thiol oxidation cycle of dichalcogenides. In the toxic pathway the formation of the selenol/tellurol is associated with a futile oxidation of low-molecular-(RSH) or protein-thiol groups (PSH) causing depletion of GSH levels and/or protein loss of function. In the therapeutic pathway organochalcogens decompose peroxides either as a substrate for TrxR or as a mimic of GPx via the formation of the selenol/selenolate or tellurol/tellurate (PhXH/ PhX-) intermediate (X can be Se or Te).
below. The activities of mitochondrial complexes were carried out independently at least 3-5 times (each series of experiment was performed in duplicate) by use of different biological samples (samples obtained from different animals).
For NADH:ubiquinone oxidoreductase (complex I) activity assay, mitochondrial membranes (0.5 mg/mL) in 100 mM phosphate buffer, were incubated with different organocompounds or rotenone (100 lM) for 10 min. The reaction was started after 10 min by adding NADH to a final concentration of 100 lM. The enzymatic activity was determined, either in the absence or presence of superoxide dismutase (SOD; 100 UI/mL) and/or catalase (CAT; 100 UI/mL), following the decrease in absorbance at 340 nm during 180 s. In order to study the efficacy of GSH to reverse the organochalcogens-induced complex I inhibition, the mitochondrial membranes were pre-incubated in phosphate buffer in the presence of organochalcogens (Ebs 25 lM; [(PhSe) 2 ] 50 lM; [(PhTe) 2 ] 50 lM for 10 min in the absence of GSH. Thereafter the membranes were washed in phosphate buffer and centrifuged at 12,000g for 10 min at 4°C to remove the organochalcogens. Then, the membranes were incubated 5 min with GSH (500 lM; to allow the potential GSH reversion of the organochalcogens-induced inhibition). Afterward the mitochondrial complex I activity was assayed as described above by determining NADH oxidation.
For NADH-cytochrome c (complexes I-III) activity assay, we carried out the experiments using two different conditions. In the condition 1, mitochondrial membranes were pre-incubated with 200 lM NADH (as substrate), 1 mM KCN and with different organocompounds or 100 lM rotenone for 10 min (pre-incubation with organocompounds in the presence of NADH). The reaction was started after addition of 100 lM cytochrome c3 (oxidized cytochrome). In the condition 2, mitochondrial membranes were pre-incubated with 100 lM cytochrome c3 (oxidized cytochrome), 1 mM KCN and with different organocompounds or rotenone preincubated for 10 min (pre-incubation with organocompounds in the absence of NADH). The reaction was then started by adding 200 lM NADH to the reaction mixture. In both conditions, the enzymatic activity was determined at 550 nm (e = 19 mM À1 cm À1 ) during 120 s.
For succinate:ubiquinone oxidoreductase (complex II) activity assay, we carried out the experiments in two different conditions. In the condition 1, mitochondrial membranes in 100 mM phosphate buffer were incubated with succinate 5 mM, different organocompounds or malonate 8 mM. In the condition 2, mitochondrial membranes were pre-incubated with different organocompounds or malonate 8 mM (pre-incubation in the absence of succinate). After 10 min of pre-incubation, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 1 mg/mL; condition 1) or MTT and succinate (5 mM; condition 2) were added to reaction medium. The reaction was stopped 3 min after MTT by adding 1 mL of ethanol and the absorbance was determined at 570 nm. In order to study the efficacy of GSH to reverse the organochalcogens-induced complex II inhibition, the mitochondrial membranes were pre-incubated in phosphate buffer in the presence of organochalcogens (Ebs 25 lM; [(PhSe) 2 ] 50 lM; [(PhTe) 2 ] 50 lM for 10 min (according condition 1) in the absence of GSH.
After, the membranes were washed in phosphate buffer to remove the organochalcogens. Afterward, centrifugations at 12,000g for 10 min at 4°C, mitochondrial membranes were resuspended in phosphate buffer. Subsequently, mitochondrial membranes were incubated with GSH (500 lM during 5 min and the mitochondrial complex II activity was assayed according to condition 1 described above (by adding MTT). Mitochondrial complex II activity was assessed by the conversion of the MTT dye to formazan. This assay is based on the reduction of MTT to formazan by mitochondrial succinate dehydrogenase (SDH). Because selenol/telurol might reduce MTT per se, we inactivated the succinate dehydrogenase by heat (10 min at 100°C) in order to discount the potential nonenzymatic reduction of MTT.
For succinate-cytochrome c reductase (complexes II-III) activity assay, mitochondrial membranes (0.5 mg/mL) were supplemented with succinate 5 mM as substrate and with 1 mM KCN, and incubated for 10 min with different organocompounds (incubation with organocompounds in the presence of succinate). The reaction was started by adding 100 lM cytochrome c3 (oxidized cytochrome). The enzymatic activity was determined at 550 nm (e = 19 mM À1 cm À1 ) during 120 s. For cytochrome oxidase (complex IV) activity assay, mitochondrial membranes (0.5 mg/mL) were incubated in 100 mM phosphate buffer for 10 min with different organochalcogens or 10 mM KCN. The reaction was started after reduced cytochrome c2 100 lM addition, and monitored during 180 s. The rate of cytochrome c2 oxidation was calculated as first-order reaction constant k per milligram protein.
Oxygen consumption measurements
Oxygen consumption was measured in an oxymeter fitted with a water-jacket Clark-type electrode (Oxytherm -Hansatech Instruments Ltd.). The intact isolated liver mitochondria (approximately 0.5 mg/mL) were pre incubated during 10 min in the standard respiration buffer (100 mM sucrose, 65 mM KCl, 10 mM K + -HEPES buffer (pH 7.2), 50 lM EGTA, 400 lM MgCl 2 ) either in the absence or presence of organochalcogens (Ebs 25 lM; (PhSe) 2 50 lM; (PhTe) 2 50 lM) in order to mimic the same conditions used to measured mitochondrial complexes activity. The oxygen consumption measurements were determined in the presence of complex I (pyruvate/glutamate 2.5 mM each) or complex II (succinate 5 mM) substrates.
Synthesis of organochalcogens
(PhSe) 2 was synthesized using the method previously described (Paulmier, 1986) , (PhTe) 2 according to Petragnani (Petragnani, 1994) and Ebs as described by Engman (Engman, 1989) . Solutions of organochalcogens were prepared freshly in dimethylsulfoxide (DMSO) and the final concentration of DMSO in each tube was 3%.
Statistical analysis
Data were analyzed by one-way ANOVA followed by Duncań s multiple range test when appropriate. The data of Figs. 3(A and B) and 4(A-C) and the effect of the respective classical inhibitors (vs. control) were analyzed by Student's t Test. Linear regression analysis was performed in order to evaluate the concentration dependence effect of organochalcogens on mitochondrial complexes. A p < 0.05 value was considered statistically significant.
Results
Effect of organochalcogens in mitochondrial complex I activity
Statistical analysis indicated that Ebs, (PhSe) 2 and (PhTe) 2 significantly inhibited complex I activity from liver and kidney mitochondria ( Fig. 1A and B, respectively) . The inhibitory effect was concentration dependent in liver membranes, as revealed by the linear regression analysis (p < 0.05 for all studied organochalcogens). Ebs-induced complex I inhibition was statistically significant from 5 lM onwards, while both (PhSe) 2 and (PhTe) 2 caused mitochondrial complex I inhibition from 10 lM onwards (Fig. 1A and B) .
The IC 50 (lM) values for inhibition by organochalcogens of mitochondrial complex I activity are showed in Table 1 . Rotenone (100 lM), a classical complex I inhibitor, caused a significant inhibition of the mitochondrial complex I activity (Fig. 1A-B) . Fig. 2 shows that Ebs significantly inhibited the complexes I-III activity from liver mitochondrial membranes from 10 lM onwards, with maximal effect at 50 lM ( Fig. 2A) . The inhibitory effect of Ebs on renal mitochondrial complexes I-III activity was statistically evident only at 50 lM (Fig. 2B ). (PhSe) 2 and (PhTe) 2 did not change the mitochondrial complexes I-III activity from liver ( Fig. 2A) or kidney (Fig. 2B) . The IC 50 (lM) values for inhibition by organochalcogens of mitochondrial complexes I-III activity are showed in Table 1 .
Effect of organochalcogens in mitochondrial complexes I-III activity
In order to better understand the inhibitory effect of different organochalcogens in mitochondrial complexes I-III activity, we carried out experiments using two different conditions. In brief, in the condition 1 the membranes were pre-incubated with the organocompounds (at different concentrations) in the presence of NADH and the reaction was started with cytochrome c3. In the condition 2, the mitochondrial membranes were pre-incubated with different concentrations of oganocompounds and cytochome c3, and the reaction was started by NADH.
Under condition 1, Ebs (5 lM) significantly inhibited complexes I-III activity from liver (Fig. 3A) , without affecting renal complexes I-III activity (Fig. 3C ). (PhSe) 2 and (PhTe) 2 did not inhibit the mitochondrial complexes I-III activity from liver or kidney (Fig. 3A and B, respectively). However, under condition 2 Ebs, (PhSe) 2 and (PhTe) 2 (5 lM) significantly inhibited complexes I-III activity from liver ( Fig. 3A) and kidney membranes (Fig. 3B) . Rotenone (100 lM) caused a significant inhibition of the mitochondrial complexes I-III activity that varied from 30% to 70% (Fig. 3A-B) .
Since inhibition of respiratory chain complex I could be at least in part mediated by reactive oxygen species (including H 2 O 2 and superoxide), we have investigated the potential protection of antioxidant enzymes on Complex I inhibition by Ebs, (PhSe) 2 and (PhTe) 2 . Results depicted in Fig. 4 indicate that complex I inhibition by Ebs, (PhSe) 2 and (PhTe) 2 was not modified by the addition of SOD (Fig. 4A) , CAT (Fig. 4B) or SOD + CAT (Fig. 4C) .
In order to test the hypothesis that organochalcogens-induced complex I inhibition is mediated by oxidation of thiol groups, we -j-Ebs, -+ -Rotenone (100 lM). The control values (without organochalcogens) were: liver 100.31 ± 4.27; kidney 100.74 ± 6.51. Data are expressed as means ± SEM from 5 independent experiments carried out in duplicate.
⁄ p < 0.05 from respective control by Duncan's multiple range test. # p < 0.05 from control by t test. investigated the efficacy of GSH to reverse the organochalcogensinduced inhibition of complex I. Fig. 5 shows that GSH (500 lM)
completely reversed the organochalcogens-induced complex I inhibition in hepatic (Fig. 5A ) and in renal (Fig. 5B) membranes.
Effect of organochalcogens in mitochondrial complex II activity
In order to check the inhibitory effect of different organochalcogens in mitochondria complex II activity, we carried out experiments at two different conditions. In brief, in condition 1 the membranes were incubated with the organocompounds (at different concentrations) in the presence of succinate 5 mM for 10 min. The reaction was stopped 3 min after MTT by addition of ethanol. In condition 2, the mitochondrial membranes were incubated with various concentrations of organocompounds in the absence of succinate for 10 min. Succinate (5 mM) and MTT were then added and the reaction stopped after 3 min by the addition of ethanol.
Statistical analysis indicates that Ebs and (PhTe) 2 significantly inhibited both hepatic and renal complex II activity in both conditions (Fig. 6) . In contrast, (PhSe) 2 did not change the mitochondrial complex II activity from liver ( Fig. 6A and B) , but inhibited renal complex II activity under condition 1 (Fig. 6C) , without inhibiting it under experimental condition 2 (Fig. 6D) . The IC 50 (lM) values for inhibition by organochalcogens of mitochondrial complex II activity, in both conditions, are showed in Table 1 . Malonate (8 mM) caused a significant inhibition of the mitochondrial complex II activity that varied from 40% to 70% inhibition (see Fig. 6A-D) . GSH (500 lM) completely reversed the organochalcogensinduced complex II inhibition both in hepatic (Fig. 7A) and renal (Fig. 7B) membranes. 
Effect of organochalcogens in mitochondrial complexes II-III activity
Ebs and (PhTe) 2 inhibited the mitochondrial complexes II-III activity from liver ( Fig. 8A) and kidney (Fig. 8B) . (PhSe) 2 did not inhibit hepatic complexes II-III activity (Fig. 8A) , but significantly inhibited renal complexes II-III activity (Fig. 8B) . The IC 50 (lM) independent experiments carried out in duplicate. ⁄ p < 0.05 from respective control by t test. # p < 0.05 condition 1 vs condition 2 by t test. values for inhibition by organochalcogens of mitochondrial complexes II-III activity are showed in Table 1 .
Effect of organochalcogens in mitochondrial complex IV activity
Statistical analysis revealed that Ebs did not modify the hepatic (Fig. 9A) or renal (Fig. 9B) complex IV activity. (PhSe) 2 slightly inhibited complex IV activity from liver and kidney ( Fig. 9A and  B) , whereas (PhTe) 2 did not change the renal complex IV activity (Fig. 9B) ; but it inhibited hepatic complex IV activity at 50 lM (Fig. 9A) . The IC 50 (lM) value for inhibition by (PhSe) 2 of mitochondrial complex IV activity is showed in Table 1 . Potassium cyanide (KCN, 10 mM) caused a significant inhibition of the mitochondrial complex IV activity that varied from 93% to 100% inhibition ( Fig. 9A  and B ).
Effects of organochalcogens in oxygen consumption in intact mitochondria
Ebs (25 lM), (PhSe) 2 (50 lM), and (PhTe) 2 (50 lM) inhibited oxygen consumption in intact liver mitochondria supported either by pyruvate/glutamate (complex I substrates; Fig. 10A ) or succinate (complex II substrate; Fig. 10B ) as substrates. For mitochondrial oxygen consumption, the inhibitory potency order was Ebs $ (PhTe) 2 > (PhSe) 2 , independent of the substrate used. In fact, Ebs and (PhTe) 2 completely inhibits oxygen consumption, whereas (PhSe) 2 was less active. Taking into account, the results obtained with intact mitochondria are in accordance with our findings using mitochondrial membranes (isolated complexes assay).
Discussion
The results presented here indicate that the hepatic and renal toxicity of organochalcogens can be, at least in part, mediated by mitochondrial dysfunction via inhibition of different mithochondrial complexes, which can explain our previous results (Puntel et al., 2010) . Here we found that mitochondrial complex I was the key complex targeted by the organocompounds (almost 100% inhibited), followed by the complex II, whereas the inhibition of complex III and complex IV was negligible. Furthermore, both hepatic and renal mitochondrial preparations seem to be similarly inhibited by organochalcogens. In fact, despite of different susceptibility of liver and kidney tissues after in vitro or in vivo exposure to organochalcogens Rocha, 2010, 2011) , isolated hepatic and renal mitochondria tended to respond similarly to the inhibitory properties of organochalcogens. Thus we suggest that the differences in the tissues susceptibility when exposed to organochalcogens Rocha, 2010, 2011) can be associated with other factors, such as differential distribution and metabolism of organochalcogens in these tissues. Moreover, here we have used mitochondrial membranes in order to study the direct effect of organochalcogens on the complexes activity to avoid indirect effects of organochalcogen on complexes via modification of mitochondrial functionality (extent of polarization, presence of additional membrane barriers, etc., for details see (Puntel et al., 2010) ). We know that the amounts or activities of specific complexes and enzymes can be useful to test specific hypotheses but should generally be held in reserve and not used as the primary assay for mitochondrial dysfunction (Brand and Nicholls, 2011) . Hence, oxygen consumption data using intact mitochondria (Fig. 10 ) validated our findings with mitochondrial membranes and suggested that the inhibition of mitochondrial complexes is involved in the reduction of oxygen consumption by intact mitochondria.
Although there are no compelling data in the literature reporting the intracellular concentrations of these chalcogenides after acute or chronic treatment, we have previously observed that exposure to toxic doses of (PhSe) 2 increased selenium deposition in liver to levels as high as 100 lM (Maciel et al., 2003) . Thus, it is reasonable to suggest that after exposure to high doses, mitochondria may play an important role in the toxicity of organochalcogens. Accordingly, (PhSe) 2 have been reported to cause cytotoxicity to a neuronal cell Data are expressed as means ± SEM from 3-4 independent experiments carried out in duplicate.
⁄ p < 0.05 from respective control by Duncan's multiple range test. # p < 0.05 without vs with GSH by t test. line from 10 lM onwards, by induction of apoptosis via ERK1/2 pathway (Posser et al., 2011) . However, literature data about the cytotoxicity of these compounds are scarce. In fact, Ebs (at 50-75 lM) was toxic to human hepatoma cells (HepG2) and induced apoptosis via disruption of mitochondrial physiology that was dependent on cellular thiol depletion (Yang et al., 2000) . The correlation of these concentrations with the concentration of organochalcogens used here in isolated mitochondria is difficult to be done. However, since authors have exposed HepG2 cells only briefly to these relatively high concentration of Ebs (50-75 lM), we can suppose that mitochondria exposure to lM concentrations of organochalcogens is plausible to occur in vitro and after in vivo exposure to high doses of these agents. However, literature has not explored the concentrations of organochalcogens that could be toxic to primary cells and there is no study about their effects on mitochondria respiration using intact cells and/or tissue slices. Thus, it is important to emphasize that this is the first report concerning the inhibitory effect of studied organochalcogens on mitochondrial complexes activity.
Taken together, our results indicate that Ebs, (PhSe) 2 , and (PhTe) 2 inhibit the activity of mitochondrial complexes I and II from liver and kidney. This inhibition probably involves the interaction of these compounds with essential cysteinyl residues of mitochondrial complexes (represented by PSH in Scheme 1), as indicated by our data using GSH (see Figs. 5 and 7) . In fact, the mitochondrial complexes (complexes I-IV) are well known to be oxidatively modified in physiological and non-physiological conditions, which can culminate with their inhibition (Beltran et al., 2000; Clementi et al., 1998; Le-Quoc et al., 1981; Navarro and Boveris, 2007; Navarro et al., 2002 Navarro et al., , 2004 Navarro et al., , 2005 Ohnishi et al., 1998) . In line with this, Ebs, (PhSe) 2 , and (PhTe) 2 were reported to inhibit d-ALA-D (Barbosa et al., 1998; Folmer et al., 2005; The control values (without organochalcogens) were: liver 101.05 ± 3.05; kidney 99.37 ± 2.03. Data are expressed as means ± SEM from 5 independent experiments carried out in duplicate.
⁄ p < 0.05 from respective control by Duncan's multiple range test. # p < 0.05 from control by t test. Fig. 10 . Effect of organochalcogens on Hepatic Mitochondrial oxygen consumption. Isolated rat liver mitochondria (0.5 mg/mL) were pre incubated 10 min in the absence or presence of different orcanochalcogens studied at indicated concentrations and the oxygen consumption was measured as described in the Materials and methods using Pyruvate/glutamate (2.5 mM each) (A) or succinate (5 mM) (B) as substrates. The arrows indicate sequential additions of: Mit, 0.5 mg/mL mitochondria; Py/Glu, 2.5 mM pyruvate and 2.5 mM glutamate; Succ, 5 mM succinate; ADP/Pi, 0.3 mM ADP and 0.6 mM inorganic phosphate; Olig, 2 lM oligomycin; and 2,4 DNP, 10 lM dinitrophenol.
-e-Control, -N-(PhSe) 2 , -d-(PhTe) 2 , -j-Ebs. Data (oxygen content in the medium) are expressed as means ± SEM from 4 independent experiments carried out in duplicate. The numbers in the Figures represent the respiratory rate (expressed as rate medium of 4 independent experiments performed in duplicates).
of these enzymes. Thus, we can hypothesize that the organochompounds studied here inhibited the mitochondrial complexes via their thiol oxidation activity (Scheme 1). Our assumption is further supported by the results presented in Fig. 3(A-B) where we have used different assay conditions. In fact, we found that incubation of mitochondrial membranes with the complex I substrate (NADH) partially prevents the inhibitory effect of chalcogens on complex I activity. Our hypothesis is further supported by previous data from our laboratory showing that (PhSe) 2 -induced LDH inhibition was attenuated or abolished by NADH (Lugokenski et al., 2011) . These data indicate that NADH can modulate enzyme conformation preventing the critical thiols from the attack by organochalcogens. Based on the presented results, we suggest that organochalcogen-induced mitochondrial complex I inhibition is linked to their interaction with critical thiol groups present in the active site of the NADH:ubiquinone oxidoreductase (Lin et al., 2002) .
As mentioned above, the complex I inhibition by organochalcogens was more pronounced than complex II. We suggest that, despite of succinate dehydrogenase (SDH) being described to possess sulfhydryl group essential for catalytic activity, located in the substrate site (Le-Quoc et al., 1981) , the organochalcogensinduced mitochondrial complex II inhibition could be due to their interaction with other thiols critical to enzyme activity, than that located in the active site of the SDH (Lin et al., 2002) . Our data are further supported by previous data showing that complex II is less prone to inactivation than complex I (Cadenas and Davies, 2000; Orrenius et al., 2007; Zhang et al., 1990) . Thus, based on the presented results (Figs. 5 and 7) we suggest that both complexes I and II were directly affected by the organochalogens, being the thiols groups the molecular site of action for the organochalcogens. Our hypothesis is further supported by the data showing that organochalcogens induced complex I inhibition was not mediated by ROS formation (Figs. 4A-C) .
However, as seen in Figs. 6 and 8, (PhSe) 2 has differential effect on complex II in liver and kidney. At the present moment, these results are not completely understood, but they can be related to differences in the molecular composition of mitochondria obtained from different tissues (Benard et al., 2006) . Thus, we speculate that the liver and kidney could present different contents and isoforms of complex II enzymes, which resulted in different inhibition by (PhSe) 2 . Our assumption is based on previous data showing that, at least, two different isoforms of complex II have been reported in the literature (Tomitsuka et al., 2003a,b; Tomitsuka et al., 2009) .
In addition to complexes I and II, the activities of the mitochondrial complexes III and IV (both from rat liver and kidney) were practically not targeted by organocompounds. In fact, mitochondrial complex III was minimally inhibited by the treatment with studied compounds, whereas complex IV was nearly unchanged. Thus, organochalcogens possibly did not inhibit mitochondrial complexes III and IV due to steric hindrance of their sulfhydryl groups to the organochalcogens (Lin et al., 2002) . Our findings are supported by previous report showing that thiol groups from complex IV are less prone to oxidation than that from complex I (Orrenius et al., 2007) .
As pointed previously, damage to the mitochondrial electron transport chain has been suggested to be an important factor in the pathogenesis of a range of diseases where the oxidative stress seems to be involved (Beltran et al., 2000; Clementi et al., 1998; Dahm et al., 2006; Fattal et al., 2006; Hurd et al., 2007; Le-Quoc et al., 1981; Madrigal et al., 2001; Navarro and Boveris, 2007; Navarro et al., 2002 Navarro et al., , 2004 Navarro et al., , 2005 Ohnishi et al., 1998; Taylor et al., 2003) . In addition, mitochondrial dysfunction (as evidenced by decline in respiratory chain activity) is closely linked to both age and ischemia-reperfusion-associated mitochondrial changes, that culminates, in some cases, to apoptotic cell death (Cadenas and Davies, 2000; Caspersen et al., 2005; Hauptmann et al., 2006; Navarro and Boveris, 2007; Nicholls, 2002; Sastre et al., 2003) . Thus, based on the presented results and in the previously published data (Puntel et al., 2010) it is reasonable to suggest that mitochondrial dysfunction could be a central process in the hepatotoxicity of organochalcogens after in vivo exposure. Kidney could also be targeted by high doses of organochalcogens; however, the deposition of these compounds in kidney is less accentuated than in liver (Maciel et al., 2003) .
In conclusion, here we clearly demonstrate that Ebs, (PhSe) 2 , and (PhTe) 2 -induced mitochondrial complexes inhibition, and that their effects virtually did not vary among the hepatic and renal mitochondria. The mitochondrial complex I was the most susceptible to organochalcogens-induced inhibition, followed by complex II. Based on our data, we believe that inhibitory effect of organochalcogens could be attributed to oxidation of essential thiols in the enzyme complexes. Taking this into account, we suggest that mitochondrial complex I and II could be considered important molecular targets of organochalcogens after exposure to high dosages of these compounds.
